MEDFAC UK LTDActive
Key figures
MEDFAC UK LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Filed accounts2019–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | — | — | 219,775 |
| Cash at bank and in hand | 953,451 | 1,173,979 | 1,041,711 | 688,257 | 626,508 |
| Total assets | 3,042,976 | 3,315,062 | 4,794,220 | 5,722,710 | 5,455,708 |
| Total liabilities | 568,486 | 684,868 | 2,224,195 | 2,774,166 | 2,364,369 |
| Net assets / total equity | 2,371,435 | 2,522,014 | 2,484,658 | 2,739,996 | 2,959,771 |
| Average number of employees | 76 | 88 | 97 | 124 | 164 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Manufacturing and sale of bespoke orthopaedic shoes.
As described in the company's latest filed accounts.
Summary: MEDFAC UK LTD
Company
MEDFAC UK LTD is a private limited company registered with Companies House under company number 08608060. It was incorporated on 12 Jul 2013. Its status is active. The registered office is in London (EC4A). Its nature of business (SIC 2007) is manufacture of other wearing apparel and accessories n.e.c. (14190).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files group accounts. Profit for the year was £219,775. Net assets were £2,959,771, up 8% on the previous year. Cash at bank and in hand was £626,508. Total assets were £5,455,708 and total liabilities £2,364,369. The company had an average of 164 employees. Figures are available for 7 financial years (2019–2025).
Control and charges
One person with significant control is registered. 2 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 30 May 2027.